RNF11 modulates microglia activation through NF-κB signalling cascade

Neuroscience Letters

Volumn 528, Issue 2, 2012, Pages 174-179

  Dalal, Nirjari V ^a   Pranski, Elaine L ^a   Tansey, Malu G ^a   Lah, James J ^a   Levey, Allan I ^a   Betarbet, Ranjita S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytotoxicity; Inflammation; Microglia; NF B; RNF11

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RING FINGER PROTEIN; RING FINGER PROTEIN 11; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; IMMUNOCOMPETENT CELL; IMMUNOPRECIPITATION; MICROGLIA; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; CARRIER PROTEINS; CELL SURVIVAL; CELLS, CULTURED; DNA-BINDING PROTEINS; HUMANS; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NEUROIMMUNOMODULATION; NF-KAPPA B; PRIMARY CELL CULTURE; RNA, MESSENGER; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84867700053     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.08.060     Document Type: Article

References (46)

1. Anderson L.R., Betarbet R., Gearing M., Gulcher J., Hicks A.A., Stefansson K., Lah J.J., Levey A.I. PARK10 candidate RNF11 is expressed by vulnerable neurons and localizes to Lewy bodies in Parkinson disease brain. Journal of Neuropathology and Experimental Neurology 2007, 66(10):955-964.
2. Andreakos E., Sacre S.M., Smith C., Lundberg A., Kiriakidis S., Stonehouse T., Monaco C., Feldmann M., Foxwell B.M. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. Blood 2004, 103(6):2229-2237.
3. Blasi E., Barluzzi R., Bocchini V., Mazzolla R., Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. Journal of Neuroimmunology 1990, 27(2-3):229-237.
4. Bonini S.A., Ferrari-Toninelli G., Uberti D., Montinaro M., Buizza L., Lanni C., Grilli M., Memo M. Nuclear factor kappaB-dependent neurite remodeling is mediated by Notch pathway. Journal of Neuroscience 2011, 31(32):11697-11705.
5. Cao S., Theodore S., Standaert D.G. Fcgamma receptors are required for NF-kappaB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease. Molecular Neurodegeneration 2010, 5:42.
6. Cardoso F.L., Kittel A., Veszelka S., Palmela I., Toth A., Brites D., Deli M.A., Brito M.A. Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cells. PLoS One 2012, 7(5):e35919.
7. Chen Y., Hallenbeck J.M., Ruetzler C., Bol D., Thomas K., Berman N.E.J., Vogel S.N. Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. Journal of Cerebral Blood Flow and Metabolism 2003, 23(6):748-755.
8. Cheong M.H., Lee S.R., Yoo H.S., Jeong J.W., Kim G.Y., Kim W.J., Jung I.C., Choi Y.H. Anti-inflammatory effects of Polygala tenuifolia root through inhibition of NF-kappaB activation in lipopolysaccharide-induced BV2 microglial cells. Journal of Ethnopharmacology 2011, 137(3):1402-1408.
9. Chinta S.J., Ganesan A., Reis-Rodrigues P., Lithgow G.J., Andersen J.K. Anti-inflammatory role of the isoflavone diadzein in lipopolysaccharide-stimulated microglia: implications for Parkinson's disease. Neurotoxicity Research 2012, 10.1007/s12640-012-9328-5.
10. Conductier G., Blondeau N., Guyon A., Nahon J.L., Rovere C. The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. Journal of Neuroimmunology 2010, 224(1-2):93-100.
11. Ghosh A., Roy A., Liu X., Kordower J.H., Mufson E.J., Hartley D.M., Ghosh S., Mosley R.L., Gendelman H.E., Pahan K. Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proceedings of the National Academy of Sciences 2007, 104(47):18754-18759.
12. Glass C.K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140(6):918-934.
13. Harhaj E.W., Dixit V.M. Deubiquitinases in the regulation of NF-kappaB signaling. Cell Research 2011, 21(1):22-39.
14. Kaltschmidt B., Kaltschmidt C. NF-kappaB in the nervous system. Cold Spring Harbor Perspectives in Biology 2009, 1(3):a001271.
15. Karin M., Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nature Reviews Immunology 2005, 5(10):749-759.
16. Kim Y.J., Hwang S.Y., Oh E.S., Oh S., Han I.O. IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways. Journal of Neuroscience Research 2006, 84(5):1037-1046.
17. Kim B.W., Koppula S., Kim J.W., Lim H.W., Hwang J.W., Kim I.S., Park P.J., Choi D.K. Modulation of LPS-stimulated neuroinflammation in BV-2 microglia by Gastrodia elata: 4-hydroxybenzyl alcohol is the bioactive candidate. Journal of Ethnopharmacology 2012, 139(2):549-557.
18. Krikos A., Laherty C.D., Dixit V.M. Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. Journal of Biological Chemistry 1992, 267(25):17971-17976.
19. Lee E.G., Boone D.L., Chai S., Libby S.L., Chien M., Lodolce J.P., Ma A. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 2000, 289(5488):2350-2354.
20. Lee J.K., Tran T., Tansey M.G. Neuroinflammation in Parkinson's disease. Journal of Neuroimmune Pharmacology 2009, 4(4):419-429.
21. Lee J.K., Chung J., McAlpine F.E., Tansey M.G. Regulator of G-protein signaling-10 negatively regulates NF-kappaB in microglia and neuroprotects dopaminergic neurons in hemiparkinsonian rats. Journal of Neuroscience 2011, 31(33):11879-11888.
22. Li H., Seth A. An RNF11. Smurf2 complex mediates ubiquitination of the AMSH protein. Oncogene 2004, 23(10):1801-1808.
23. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nature Reviews Immunology 2002, 2(10):725-734.
24. Liu B., Hong J.S. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. Journal of Pharmacology and Experimental Therapeutics 2003, 304(1):1-7.
25. Magne N., Toillon R.A., Bottero V., Didelot C., Houtte P.V., Gerard J.P., Peyron J.F. NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment. Cancer Letters 2006, 231(2):158-168.
26. Mattson M.P., Camandola S. NF-κB in neuronal plasticity and neurodegenerative disorders. The Journal of Clinical Investigation 2001, 107(3):247-254.
27. Mattson M.P., Meffert M.K. Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death and Differentiation 2006, 13(5):852-860.
28. Muroya M., Chang K., Uchida K., Bougaki M., Yamada Y. Analysis of cytotoxicity induced by proinflammatory cytokines in the human alveolar epithelial cell line A549. BioScience Trends 2012, 6(2):70-80.
29. Nelson P.T., Soma L.A., Lavi E. Microglia in diseases of the central nervous system. Annals of Medicine 2002, 34(7-8):491-500.
30. Nguyen M.D., Julien J.P., Rivest S. Innate immunity: the missing link in neuroprotection and neurodegeneration?. Nature Reviews Neuroscience 2002, 3(3):216-227.
31. O'Neill L.A., Kaltschmidt C., NF-kappa B. a crucial transcription factor for glial and neuronal cell function. Trends in Neurosciences 1997, 20(6):252-258.
32. Perry V.H., Nicoll J.A., Holmes C. Microglia in neurodegenerative disease. Nature Reviews Neurology 2010, 6(4):193-201.
33. Pranski E.L., Dalal N.V., Herskowitz J.H., Orr A.L., Roesch L.A., Fritz J.J., Heilman C., Lah J.J., Levey A.I., Betarbet R.S. Neuronal RING finger protein 11 (RNF11) regulates canonical NF-kappaB signaling. Journal of Neuroinflammation 2012, 9(1):67.
34. Pranski E.L., Van Sanford C.D., Dalal N.V., Orr A.L., Karmali D., Cooper D.S., Costa N., Heilman C.J., Gearing M., Lah J.J., Levey A.I., Betarbet R.S. Comparative distribution of protein components of the A20 ubiquitin-editing complex in normal human brain. Neuroscience Letters 2012, 510(1):104-109.
35. Puntambekar S.S., Doose J.M., Carson M.J. Microglia A CNS-specific tissue macrophage. Central Nervous System Diseases and Inflammation 2008, vol. 1:1-12. Springer, New York.
36. Sharif O., Bolshakov V.N., Raines S., Newham P., Perkins N.D. Transcriptional profiling of the LPS induced NF-kappaB response in macrophages. BMC Immunology 2007, 8:1.
37. Shembade N., Harhaj E. A20 inhibition of NFkappaB and inflammation: targeting E2:E3 ubiquitin enzyme complexes. Cell Cycle 2010, 9(13):2481-2482.
38. Shembade N., Harhaj N.S., Liebl D.J., Harhaj E.W. Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling. EMBO Journal 2007, 26(17):3910-3922.
39. Shembade N., Harhaj N.S., Parvatiyar K., Copeland N.G., Jenkins N.A., Matesic L.E., Harhaj E.W. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nature Immunology 2008, 9(3):254-262.
40. Shembade N., Parvatiyar K., Harhaj N.S., Harhaj E.W. The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-[kappa]B signalling. EMBO Journal 2009, 28(5):513-522.
41. Shembade N., Ma A., Harhaj E.W. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 2010, 327(5969):1135-1139.
42. Subramaniam V., Li H., Wong M., Kitching R., Attisano L., Wrana J., Zubovits J., Burger A.M., Seth A. The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase. British Journal of Cancer 2003, 89(8):1538-1544.
43. Tran T., McCoy M., Sporn M., Tansey M. The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection. Journal of Neuroinflammation 2008, 5(1):14.
44. Ueda A., Ishigatsubo Y., Okubo T., Yoshimura T. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. Journal of Biological Chemistry 1997, 272(49):31092-31099.
45. van der Kooij M.A., Nijboer C.H., Ohl F., Groenendaal F., Heijnen C.J., van Bel F., Kavelaars A. NF-kappaB inhibition after neonatal cerebral hypoxia-ischemia improves long-term motor and cognitive outcome in rats. Neurobiology of Disease 2010, 38(2):266-272.
46. Wyss-Coray T., Mucke L. Inflammation in neurodegenerative disease-a double-edged sword. Neuron 2002, 35(3):419-432.